Articles On Telix Pharmaceuticals (ASX:TLX)

This month I’ve been looking at a number of shares that Bell Potter has rated as its top picks for FY 2023. You can read about its tech picks here and its energy picks here. On this occasion, let’s take a look at a couple of ASX health...

Telix Pharmaceuticals (TLX) signs a licence and distribution agreement with Isologic Innovative Pharmaceuticals for its investigational prostate cancer imaging agent Illuccix Under the agreement, Isologic will be the commercial distributor...

Aussie shares sank to their lowest level since November 2020 as recession fears continued to batter financial markets. The S&P/ASX 200 dived 136 points or 2.07 per cent towards a sixth straight loss. Barring a miraculous afternoon re...

MELBOURNE, Australia and BOSTON, June 14, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has advanced a partnership with Invicro LLC (Invicro), a global, industry-leading imaging...

MELBOURNE, Australia and BOSTON, June 14, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has advanced a partnership with Invicro LLC (Invicro), a global, industry-leading imaging...

Telix Pharmaceuticals (ASX:TLX) and US-based RefleXion Medical have signed a new co-development and commercialisation agreement.

MELBOURNE, Australia and INDIANAPOLIS, June 13, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce that its prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga...

MELBOURNE, Australia and INDIANAPOLIS, June 10, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RefleXion Medical, Inc. (Hayward, California, U.S.) (RefleXion) today announced the signing of a co-dev...

ShareCafeLunch Report: 10 June, 2022 by Lauren Evans   The Aussie sharemarket is off to another weak start following a red finish on Wall Street. Australian shares are on track for their largest weekly decline this year as markets digest th...

Telix Pharmaceuticals (TLX) signs a partnership for prostate cancer treatment with RefleXion Medical The parties agreed to sign a co-development and commercialisation agreement to expand the use of Telix’s prostate cancer imaging agent Ill...

10 Jun 2022 - A snapshot of the stocks on the move featuring Bubs Australia (ASX:BUB), Telix Pharmaceuticals (ASX:TLX), Terracom (ASX:TER) & Medallion Metals (ASX:MM8).

Telix Pharma’s Illucix could be used in BgRT radiotherapies in the US Chimeric Therapeutics advances its CAR T therapy program Telix expands partnership with US-based RefleXion Telix Pharma (ASX:TLX) has expanded its partnership with Cali...

Telix Pharmaceuticals (ASX:TLX) has received a $17.25 million R&D tax refund from the federal government for eligible activities undertaken in the year ended 31 December 2021.

MELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic pr...

ShareCafeEvening Report: 7 June, 2022 by Melissa Darmawan   The cost of living is set to rise after the Reserve Bank of Australia (RBA) raised the cash rate by 50 basis points versus the expected 40, sending the ASX 200 to a three week low,...

Highlights XAO or All Ords entails the 500 largest companies on the ASX XAO is down by nearly 5.19% on a YTD basis, as of 7 June 2022 The healthcare space has witnessed great developments amid the COVID-19 outbreak. The All Ordina...

Australian shares suffered their heaviest loss in more than three weeks after the Reserve Bank raised its benchmark rate by 50 basis points to 0.85 per cent. The dollar jumped and shares slumped when news of the bumper hike was released....

07 Jun 2022 - A snapshot of the stocks on the move featuring, Yancoal (ASX:YAL), GQG Partners (ASX:GQG), Telix Pharmaceuticals (ASX:TLX), and Kingston Resources (ASX:KSN).

Shares fell for a second day as downbeat economic data underlined cost of living pressures ahead of an expected rate rise this afternoon.   A broad sell-off drove the S&P/ASX 200 down 63 points or 0.88 per cent by mid-session. All...

Highlights The Australian equity market opened lower today as the benchmark index ASX 200 index was down 0.58% at 7,164.80 points in the opening hours of trading All the top four ASX-listed banks slipped into the red ahead of RBA’s int...

The ASX 200 is set to open lower this morning RBA will announce interest rates decision at 2.30pm AEST Bitcoin is back over US$31k again Aussie shares will open marginally lower this morning ahead of the RBA decision, despite US stocks ri...

MELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its presence at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting...

The share market dropped 0.8 per cent following pressure on US stocks as the threat of significantly higher interest rates dampened buying interest.   The S&P/ASX 200 declined 58 points to 7165. Tech stocks led a sell-off in sectors...

ShareCafeEvening Report: 1 June, 2022 by Lauren Evans   The Australian sharemarket held on to its gains in the afternoon session despite a big drop in lithium miners. Communication services led the pack up nearly 2 per cent, followed by fin...

Mesoblast reports quarterly trading revenues Telix appoints new executives Osprey restructures business, in trading halt Cellular medicines specialist Mesoblast (ASX:MSB) says its revenues in the third quarter increased by 5% on the same...

ShareCafeLunch Report: 1 June, 2022 by Lauren Evans   The Aussie sharemarket is pushing higher this morning after Wall Street fell overnight amid inflation and recession fears across the globe. Most sectors are showing gains, with the excep...

Telix Pharmaceuticals (TLX) announces a number of changes to its executive leadership team to enable the company to move into its next phase of growth The company has appointed Darren Smith as Chief Financial Officer, replacing Doug Cubbin...

01 Jun 2022 - Darren Smith will take over Doug Cubbin as chief financial officer of Telix Pharmaceuticals (ASX:TLX).

ShareCafeEvening Report: 30 May, 2022 by Lauren Evans   The ASX 200 rose for a second successive day led by technology, materials and bank shares. At the closing bell, the index was 1.5 per cent or 104 points higher at 7,287, its best perfo...

ASX 200 was up 1.3% today, led by Tech which jumped 4% A2M rose 10% after Bubs got  export deal with the US AGL Energy cancels coal demerger plan   A surge in Tech stocks led the ASX to a 1.3% higher close today, following a strong rally...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and is charging higher. At the time of writing, the benchmark index is up 1.1% to 7,259.6 points. Four ASX shares that are climbing more than most tod...

ShareCafeLunch Report: 30 May, 2022 by Melissa Darmawan   Australian shares jumped to a three week high after a strong lead from Wall St. Every sector is rallying, bar utilities after news from AGL. The optimism is led by technology shares,...

30 May 2022 - A snapshot of the stocks on the move featuring Telix Pharmaceuticals (ASX:TLX), Australian Unity Office Fund (ASX:AOF) & Yancoal (ASX:YAL).

Invion demonstrates high efficacy of INV043 when used as a combined therapy Biotron gets positive feedback from US FDA Biome stocks its Probiotics range on Priceline’s shelves Invion demonstrates efficacy Cancer fighter Invion (ASX:IVX) w...

MELBOURNE, Australia and INDIANAPOLIS, May 30, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on the U.S. and Australian launch and reimbursement status for its prostate cancer i...

Friday has brought good news for embattled investors. DeVere Group CEO and founder Nigel Green has tipped that major global indexes – such as the S&P/ASX 200 Index (ASX: XJO) – could be nearing their lowest point and getting ready to r...

ShareCafeLunch Report: 18 May, 2022 by Melissa Darmawan   Materials lift ASX higher for 4th day Australian shares are on track to continue its winning streak for its fourth straight day after taking a strong lead from Wall St. The local ind...

World Overnight SPI Overnight 7181.00 + 70.00 0.98% S&P ASX 200 7112.50 + 19.50 0.27% S&P500 4088.85 + 80.84 2.02% Nasdaq Comp 11984.52 + 321.73 2.76% DJIA 32654.59 + 431.17 1.34% S&P500 VIX 26.10 – 1.37 – 4.99%...

Australian shares were poised to open higher for a fourth day after strong retail sales doused fears of an economic slowdown in the US.   Wall Street’s main indices closed sharply higher as a rebound from six weeks of steady decline gath...

Australian stocks were poised to open higher as lockdown news out of China over the weekend added to positive leads from Wall Street and commodity markets.   ASX futures rallied 54 points or 0.77 per cent on Friday night as US stocks sur...

Australian shares rebounded strongly this session but could not avert a fourth straight weekly decline as financial markets continued to factor in the risk of a global slowdown as rates rise and China pursues zero-Covid. An end-of-week r...

A relief rally lifted the ASX 200 back above the 7000 level as a pause in this week’s bloodletting on Wall Street brought buyers back to market. The S&P/ASX 200 bounced 95 points or 1.36 per cent to 7036 by mid-session. The rally bro...

You might be sick of hearing this, but turbulent times like now mean it’s more important than ever to retain a long-term view of ASX shares. You might look at a particular stock and be horrified that it has dropped half its value this year...

The share market logged its weakest close since January as the tech sector slumped to a two-year low and the dollar fell below 69 US cents. Borrowing-dependent growth stocks bore the brunt as the S&P/ASX 200 tumbled 124 points or 1.7...

Highlights: Race Oncology is riding high with governance approval for human trial of its new therapy Zantrene®. The cancer drug will be studied in patients with extramedullary Acute Myeloid Leukaemia (AML) or high-risk Myelodysplastic...

Biotechnology ASX shares have been one of the biggest victims of persistent inflation and rising interest rate fears over the past 6 months.  The S&P/ASX 300 Pharmaceuticals & Biotechnology (ASX: AXPBKD) has lost about 15% over tha...

Some of the worst-performing corners of the market enjoyed a day in the sun after a relief rally on Wall Street inspired the ASX’s first advance this week. Gold miners, tech companies and small and micro caps outperformed as the S&P/...

Tech and commodity stocks steered the share market towards its first gain of the week following Wall Street’s best session since 2020. The S&P/ASX 200 overcame an early wobble to advance 44 points or 0.6 per cent by mid-session. T...

MELBOURNE, Australia and INDIANAPOLIS, May 5, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in the ‘STARLITE 2’ Phase II study of the Company’s invest...

Highlights Gains in the market were broad-based today with all the 11 individual sectors ending in the positive territory. The IT sector rose 2.25% on Friday followed by Telecom and Consumer Discretionary, which added 1.89% and 1.46% r...